Coronavirus (No politics)

@kiddiedoc using the world meter data it shows around a 1.5% current mortality rate. That is actually lower than start if the week. Is there anything meaningful to read into that yet or is it still too early to predict active case ultimate outcomes at maintaining that current and declining mortality rate. I’ve been watching it and I think I saw a peak at 1.8%? TIA and keep up the awesome work brother.
 
@kiddiedoc using the world meter data it shows around a 1.5% current mortality rate. That is actually lower than start if the week. Is there anything meaningful to read into that yet or is it still too early to predict active case ultimate outcomes at maintaining that current and declining mortality rate. I’ve been watching it and I think I saw a peak at 1.8%? TIA and keep up the awesome work brother.
I believe this apparent drop in mortality rate is a function of more readily-available testing. I.e.: a larger number of people with mild to moderate symptoms are getting tested and diagnosed, increasing the denominator.
 
  • Like
Reactions: berryvol and AM64
I believe this apparent drop in mortality rate is a function of more readily-available testing. I.e.: a larger number of people with mild to moderate symptoms are getting tested and diagnosed, increasing the denominator.
That makes sense but that also addresses what I was trying to ask. Now that we’ve got a larger more representative sample our own observed mortality rate appears much lower than the global rate. Still too early to read much into that with our active case population due to the length of recuperation?
 
@kiddiedoc doc, Can you address this? This was mentioned on Late night tv as a possible temporary solution. If this has already been discussed I apologize.Drugs & Medications Hydroxychloroquine
So, the only available literature right now suggests that hydroxy-/chloroquine has been at least somewhat effective in "pre-clinical use." It also inhibits the SARS-CoV-2 virus in vitro. A large number of clinical trials are underway.

Remdesivir is another medication that has promise. It is also being studied extensively, as are other antivirals.
 
That makes sense but that also addresses what I was trying to ask. Now that we’ve got a larger more representative sample our own observed mortality rate appears much lower than the global rate. Still too early to read much into that with our active case population due to the length of recuperation?

I would say so, yes.

Also, bear in mind that we are only seeing the earliest reports of positive tests. Most of the ones that have been sent in the last 2-3 days won't be back until end of the week.
 
People with blood type A might be more vulnerable to the coronavirus, while those with type O blood could be more resistant, according to a new preliminary study from China.

Researchers studying COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen found the proportion of Type-A patients both infected and killed by the disease to be “significantly” higher than those with the same blood type in the general public.

Type O patients, meanwhile, made up a smaller proportion of both those infected and killed by the virus.
 
  • Like
Reactions: BennesseeVols
People with blood type A might be more vulnerable to the coronavirus, while those with type O blood could be more resistant, according to a new preliminary study from China.

Researchers studying COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen found the proportion of Type-A patients both infected and killed by the disease to be “significantly” higher than those with the same blood type in the general public.

Type O patients, meanwhile, made up a smaller proportion of both those infected and killed by the virus.
A positive or negative?
 
People with blood type A might be more vulnerable to the coronavirus, while those with type O blood could be more resistant, according to a new preliminary study from China.

Researchers studying COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen found the proportion of Type-A patients both infected and killed by the disease to be “significantly” higher than those with the same blood type in the general public.

Type O patients, meanwhile, made up a smaller proportion of both those infected and killed by the virus.
Well I'm good then
 
Here's the latest:

• In the United States, there are at least 7,000 cases across all 50 states, plus Puerto Rico, the U.S. Virgin Islands and Washington D.C. At least 111 have died from the virus.
• The president tweeted Wednesday that the northern U.S. border would be closed to all non-essential traffic. He said trade would not be impacted by the border shutdown.
• Several states are closing bars and restaurants, but encouraged restaurants to offer takeout and delivery. Some states have postponed primary elections.
• President Trump recommended that people don't gather in groups of more than 10 people and declared a national emergency.
• Treasury Secretary Steven Mnuchin is working with Congress to get checks sent to all U.S. households to stimulate the economy along with a 90-day delay for tax payments.
 
I believe this apparent drop in mortality rate is a function of more readily-available testing. I.e.: a larger number of people with mild to moderate symptoms are getting tested and diagnosed, increasing the denominator.

Do you think we can put a stake in the ground at this point? Taking the conservative approach, one has to consider the Closed Case statistics vs the Open Case statistics. While I don't think the mortality rate will be ~50% or whatever it is for closed cases, didn't all of critical cases begin with mild symptoms?
 
To my point above, I'm not sure it's truly gotten here yet. I don't want to come off as an alarmist, but I don't think there's any current data that will paint a clear picture as to just how impactful this is.
 
  • Like
Reactions: berryvol
People with blood type A might be more vulnerable to the coronavirus, while those with type O blood could be more resistant, according to a new preliminary study from China.
Researchers studying COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen found the proportion of Type-A patients both infected and killed by the disease to be “significantly” higher than those with the same blood type in the general public.
Type O patients, meanwhile, made up a smaller proportion of both those infected and killed by the virus.

Saw this yesterday too. IMO the word "significant" is a very bad choice of descriptor, if you look at the numbers. "Moderate" seems like a better word.

The Wuhan general public has 31.6% of people with type A, while 37.7% of hospitalized patients had type A, and 41.3% of the patients that died had type A.
The Wuhan general public has 33.8% of people with type O, while 25.8% of hospitalized patients had type O, and 25.2% of the patients that died had type O.

It would seem that there would need to be a much greater disparity in the numbers for the use of the word "significantly"

Also stated in the article:
"Though the team, led by Wang Xinghuan, couched the study as “preliminary,” with more work needed to be done to develop concrete findings. "

"“If you are type A, there is no need to panic. It does not mean you will be infected 100 percent,” Gao Yingdai, a researcher in the city of Tianjin, told the outlet. “If you are type O, it does not mean you are absolutely safe, either. You still need to wash your hands and follow the guidelines issued by authorities.” "
 
  • Like
Reactions: Hoosier_Vol
To my point above, I'm not sure it's truly gotten here yet. I don't want to come off as an alarmist, but I don't think there's any current data that will paint a clear picture as to just how impactful this is.
It's been here longer than you think IMO. I'd say at least since December. Especially with all the travel around Christmas and New Years
 
I've seen a push for grocery stores giving their first hour of daily business to elderly folk. It's a nice sentiment, but giving the first hour to the generation that starred in the TV hit "Hoarders" may not be a great idea.

There's no chance I'm up at that time of day - don't know how many there are like me; but after retirement, there's almost no way I'm getting out of bed to meet somebody else's schedule come hell or high water or Coronavirus.
 
  • Like
Reactions: Slydell
So, the only available literature right now suggests that hydroxy-/chloroquine has been at least somewhat effective in "pre-clinical use." It also inhibits the SARS-CoV-2 virus in vitro. A large number of clinical trials are underway.

Remdesivir is another medication that has promise. It is also being studied extensively, as are other antivirals.

If chloroquine is a relatively safe drug and shows promise in trials, should it be considered for prophylactic use in an at risk population? Maybe even started now for the most at risk?
 
Last edited:
  • Like
Reactions: Hoosier_Vol
I'm more and more intrigued by the differences in how employers are handling it.

I know most of the larger contractors in Oak Ridge have emptied out their office people and management types to work from home, but the workers in the field are still reporting like normal. They haven't went to an Essential Only plan yet.

One of them is even working tons of overtime this week.

Its odd, especially considering the close working quarters, large meetings, etc.
 
I agree. What I meant was that it hasn't hit its peak.


Read somewhere earlier today that according to the way it's played out in China, Italy and other places next week is likely to be the worst week for the outbreak here in the US and then the cases are likely to start going down quickly. Again, not sure what truth there is to it but just passing it along....
 
Advertisement



Back
Top